DexCom, Inc. vs Prudential Financial Inc — how do they compare? DexCom, Inc. trades at $84.14 (market cap $31.86B), while Prudential Financial Inc trades at $113.2 (market cap $39.17B). The key difference: Prudential Financial Inc is the larger of the two by market cap, and Prudential Financial Inc pays a 4.93% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Prudential Financial Inc for 145 Days on average.
| DXCM | PRU | |
|---|---|---|
Market Cap | $31.86B | $39.17B |
Volume | 3,607,070 | 1,436,917 |
Sector | Health | Financials |
52-Week High | $92.34 | $125.13 |
52-Week Low | $54.84 | $92.00 |
Typical Hold Time | 62 Days | 145 Days |
Enterprise Value | $31.32B | $67.95B |
Dividend Yield | — | 4.93% |
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.03, down 0.32% on the day, with strong fundamental performance including three consecutive quarterly EPS beats and robust 20.12% net income margin. The stock shows bearish technical signals with price near pivot point support at $84, while analyst consensus remains overwhelmingly positive with 81% buy ratings and $95.07 price target representing 13% upside potential. Recent news highlights expansion opportunities in Type 2 diabetes care and executive promotions.
DXCM presents a compelling growth story with expanding profit margins and consistent earnings outperformance, though technical weakness and premium valuation create near-term headwinds. The company's leadership in continuous glucose monitoring and Type 2 diabetes market expansion provide long-term catalysts, while competition and reimbursement risks require monitoring.
Prudential Financial (PRU) trades at $112.97, up 0.54% with a bearish technical signal despite recent earnings beats. The stock shows attractive valuation metrics with P/E of 10.29 and P/S of 0.61, while maintaining solid profitability with 6.04% net margin and 12.46% ROE. Recent strategic moves include the Alexforbes stake sale and rebranding to Prudential Wealth Advisors, reflecting focus on core operations.
While PRU offers value appeal through strong fundamentals and dividend yield, investors face headwinds from bearish technicals and mixed analyst sentiment. The company's capital rotation strategy and PGIM growth initiatives provide upside potential, but execution risks and market volatility remain concerns. Current price sits above consensus target of $105.67, suggesting limited near-term upside.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →